News

Lausanne - Switzerland has ranked fifth in the IMD World Digital Competitiveness Ranking 2023, retaining the previous year’s position. It ranked top in the knowledge factor, but the jury criticized Switzerland’s rejection of digital identity and the fact that digital banking is less developed than in other countries.

Kilchberg/Delft - Cradle has raised 24 million dollars in a Series A funding round. The biotech startup has developed a platform that enables biologists to design and optimize proteins faster than ever before. It is based on generative artificial intelligence and machine learning.

Schlieren - Kuros Biosciences has received approval in the USA for the use of MagnetOs Flex Matrix in the interbody space. This means that the bone substitute has been cleared for use in all spinal implants.

Zollikofen/Zurich - Customers of the digitalization and IT service provider T-Systems Switzerland are to benefit from BLP Digital's solution for the automated processing of documents using artificial intelligence. Unlike comparable solutions, the system is ready to use within a few weeks.

Zurich/Frankfurt am Main - The regulated Swiss digital stock exchange, SIX Digital Exchange (SDX), is now using technology from the trading and brokerage firm DLT Finance, which has been licensed by BaFin in Germany. Its subsidiary DLT Securities will in future serve as a fully embedded counterparty for brokerage and trading.

Zug/Sulgen - Metall Zug and Miele are establishing a joint venture. Metall Zug will integrate its business units specializing in the disinfection and sterilization of hospitals, while Miele will contribute the Italian subsidiary Steelco. The joint venture is to be headquartered in Zug.

Zurich - Researchers from the Zurich University of the Arts (ZHdK) have developed a foldable applicator for the implantation of pacemakers. With 3Fold, the application time is significantly reduced and surgical hygiene improved. The 3Fold was named as the winner of the Design Prize Switzerland 2023.

Zurich/Basel - Researchers from the Swiss Federal Institute of Technology in Zurich (ETH) have developed an Artificial Intelligence (AI) model that accelerates the development of new drugs and optimization of existing medications. To this end, the researchers are collaborating with Roche.

Zurich/Kortrijk - The Belgian hospital AZ Groeninge is set to introduce PIPRA’s cutting-edge technology. This can pre-operatively assess the extent of the risk that older patients might develop post-operative delirium. Furthermore, the two partners are now starting to develop a tool of this kind for intensive care patients.